Understanding how sleep affects brain degeneration in Alzheimer's disease
Deciphering the molecular interplay of sleep and neurodegeneration with Drosophila
This study is looking at how sleep problems might be connected to brain issues in Alzheimer's disease, using fruit flies to find out how a certain protein affects both sleep and brain health, with the hope of discovering new ways to help improve sleep and protect the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11013324 on NIH RePORTER |
What this research studies
This research investigates the relationship between sleep and neurodegeneration, particularly in the context of Alzheimer's disease. Using a model organism called Drosophila (fruit flies), the study aims to uncover the molecular mechanisms that link disrupted sleep to brain degeneration. By examining the effects of a specific protein associated with neurodegenerative diseases, the research seeks to identify potential therapeutic pathways that could improve sleep and, in turn, brain health. The approach includes high-throughput genetic screening to explore how sleep disturbances may contribute to the progression of neurodegenerative conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with Alzheimer's disease who experience sleep disturbances.
Not a fit: Patients with neurodegenerative diseases not related to sleep disturbances may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve sleep and slow down the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between sleep and neurodegeneration, but this specific approach using Drosophila is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Kayser, Matthew S — University of Pennsylvania
- Study coordinator: Kayser, Matthew S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.